CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
May 1, 2007, 00:00
10.1016/S1098-3015(10)68568-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)68568-3/fulltext
Title :
CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68568-3&doi=10.1016/S1098-3015(10)68568-3
First page :
Section Title :
Open access? :
No
Section Order :
78